Abstract: The present invention relates to novel muteins derived from human tear lipocalin. The invention also refers to a corresponding nucleic acid molecule encoding such mutein and to a method for its generation. The invention further refers to a method for producing such a mutein. Finally, the invention is directed to a pharmaceutical composition comprising such a lipocalin mutein as well as to various uses of the mutein.

Abstract: The present invention relates to novel muteins derived from human tear lipocalin. The invention also refers to a corresponding nucleic acid molecule encoding such a mutein and to a method for its generation. The invention further refers to a method for producing such a mutein. Finally, the invention is directed to a pharmaceutical composition comprising such a lipocalin mutein as well as to various uses of the mutein.

Abstract: The present invention relates to novel muteins derived from human tear lipocalin. The invention also refers to a corresponding nucleic acid molecule encoding such a mutein and to a method for its generation. The invention further refers to a method for producing such a mutein. Finally, the invention is directed to a pharmaceutical composition comprising such a lipocalin mutein as well as to various uses of the mutein.

Abstract: The present invention relates to novel muteins derived from human tear lipocalin. The invention also refers to a corresponding nucleic acid molecule encoding such a mutein and to a method for its generation. The invention further refers to a method for producing such a mutein. Finally, the invention is directed to a pharmaceutical composition comprising such a lipocalin mutein as well as to various uses of the mutein.

Abstract: A security fence for swimming pools is provided to be so positioned as to surround the water of a swimming pool. The security fence comprises fence sections which are linked to an alarm system. The fence sections are moveable between a non-signaling position and an alarm signaling position. When the fence sections are in the non-signaling position and a given fence section is engaged with sufficient force it is moved to the alarm signaling position thereby signaling the alarm. The foregoing prevents a user, such as a child, from entering the pool water when the alarm system has been activated.

Abstract: An adaptive content platform and application integration of with the platform is described. The adaptive content platform includes one or more content-enabled, dependent applications forming an application layer and a services layer that has services shared by the each of the one or more content-enabled, dependent applications. The services layer includes at least workflow, repository, and publishing services. Each content-enabled, dependent application is object modeled in the repository services in a hierarchical structure. The object types modeled in the repository may have content associated with them. The content may be stored in a data layer that is in communications with the services layer.

Abstract: Improved compositions and methods for controlling coleopteran pests are disclosed. In particular, novel combinations of insecticidal proteins having improved toxicity to coleopteran insect pests such as corn rootworm are provided. Further, a method of killing or controlling coleopteran insect pests using the compositions of the invention is disclosed.

Abstract: The present invention relates to novel muteins derived from human tear lipocalin. The invention also refers to a corresponding nucleic acid molecule encoding such a mutein and to a method for its generation. The invention further refers to a method for producing such a mutein. Finally, the invention is directed to a pharmaceutical composition comprising such a lipocalin mutein as well as to various uses of the mutein.

Abstract: The present invention relates to novel muteins derived from human tear lipocalin. The invention also refers to a corresponding nucleic acid molecule encoding such a mutein and to a method for its generation. The invention further refers to a method for producing such a mutein. Finally, the invention is directed to a pharmaceutical composition comprising such a lipocalin mutein as well as to various uses of the mutein.

Abstract: A security fence for swimming pools is provided to be so positioned as to surround the water of a swimming pool. The security fence comprises fence sections which are linked to an alarm system. The fence sections are moveable between a non-signaling position and an alarm signaling position. When the fence sections are in the non-signaling position and a given fence section is engaged with sufficient force it is moved to the alarm signaling position thereby signaling the alarm. The foregoing prevents a user, such as a child, from entering the pool water when the alarm system has been activated.

Abstract: A security fence for swimming pools is provided to be so positioned as to surround the water of a swimming pool. The security fence comprises fence sections which are linked to an alarm system. The fence sections are moveable between a non-signaling position and an alarm signaling position. When the fence sections are in the non-signaling position and a given fence section is engaged with sufficient force it is moved to the alarm signaling position thereby signaling the alarm. The foregoing prevents a user, such as a child, from entering the pool water when the alarm system has been activated.

Abstract: An adaptive content platform and application integration of with the platform is described. The adaptive content platform includes one or more content-enabled, dependent applications forming an application layer and a services layer that has services shared by the each of the one or more content-enabled, dependent applications. The services layer includes at least workflow, repository, and publishing services. Each content-enabled, dependent application is object modeled in the repository services in a hierarchical structure. The object types modeled in the repository may have content associated with them. The content may be stored in a data layer that is in communications with the services layer.

Abstract: An adaptive content platform and application integration of with the platform is described. The adaptive content platform includes one or more content-enabled, dependent applications forming an application layer and a services layer that has services shared by the each of the one or more content-enabled, dependent applications. The services layer includes at least workflow, repository, and publishing services. Each content-enabled, dependent application is object modeled in the repository services in a hierarchical structure. The object types modeled in the repository may have content associated with them. The content may be stored in a data layer that is in communications with the services layer.

Abstract: A security fence for swimming pools is provided to be so positioned as to surround the water of a swimming pool. The security fence comprises fence sections which are linked to an alarm system. The fence sections are moveable between a non-signaling position and an alarm signaling position. When the fence sections are in the non-signaling position and a given fence section is engaged with sufficient force it is moved to the alarm signaling position thereby signaling the alarm. The foregoing prevents a user, such as a child, from entering the pool water when the alarm system has been activated.

Abstract: The present invention relates to novel muteins derived from human tear lipocalin. The invention also refers to a corresponding nucleic acid molecule encoding such a mutein and to a method for its generation. The invention further refers to a method for producing such a mutein. Finally, the invention is directed to a pharmaceutical composition comprising such a lipocalin mutein as well as to various uses of the mutein.

Abstract: The present invention relates to isolated nucleic acid molecule comprising the untranslated region of SEQ ID NO: 1, 2 or 3. The invention also relates to chimeric genes comprising SEQ ID NO: 2 operatively linked to the coding sequence of a gene of interest and to plant transformation vectors comprising the chimeric genes of the invention. The invention further relates to transgenic plants, plant cells, plant seeds, plant tissues, or plant plastids comprising the chimeric gene.

Abstract: The present invention relates to isolated nucleic acid molecule comprising the untranslated region of SEQ ID NO: 1, 2 or 3. The invention also relates to chimeric genes comprising SEQ ID NO: 2 operatively linked to the coding sequence of a gene of interest and to plant transformation vectors comprising the chimeric genes of the invention. The invention further relates to transgenic plants, plant cells, plant seeds, plant tissues, or plant plastids comprising the chimeric gene.

Abstract: The present invention relates to isolated nucleic acid molecule comprising the untranslated region of SEQ ID NO:2, which is functional as a promoter in plant plastids. The invention also relates to chimeric genes comprising SEQ ID NO:2 operatively linked to the coding sequence of a gene of interest and to plant transformation vectors comprising the chimeric genes of the invention. The invention further relates to transgenic plants, plant cells, plant seeds, plant tissues, or plant plastids comprising the chimeric genes.

Abstract: The present invention relates to the field of plastid transformation. The invention provides transformation vectors and methods to obtain transplastomic plants or algae having a transformed plastid comprising the steps of introducing into plastids a recombinant nucleic acid molecule or vector, and two phases of selection with first selection phase using a non-lethal compound and a second selection phase using a lethal compound. Alternatively, the dual selection method is conducted simultaneously using a lower concentration of the lethal compound.

Abstract: The present invention relates to isolated nucleic acid molecule comprising a nucleic acid promoter or untranslated region comprising the nucleic acid sequence of SEQ ID NO: 1, 2 or 3. The invention also relates to isolated nucleic acid promoter or untranslated region comprising the nucleic acid sequence of SEQ ID NO: 1, 2 or 3. The invention further relates to chimeric genes comprising the isolated nucleic acid promoter or untranslated region of SEQ ID NO:1, 2 or 3 operatively linked to the coding sequence of a gene of interest. The invention also relates to plant transformation vectors comprising the chimeric genes of the invention. The invention further relates to transgenic plants, plant cells, plant seeds, plant tissues, or plant plastids, comprising the chimeric genes of this invention.